Chapter 9 New Nonpeptide-Binding GPCRs as Targets for Diabetes and the Metabolic Syndrome
作者： Matthew C.T. Fyfe , Hilary A. Overton , Martin J. Procter , Christine Reynet , Jonathan R. White
DOI: 10.1016/S0065-7743(07)42009-7
关键词:
摘要: Publisher Summary This chapter describes research aimed at discovering modulators of new nonpeptide-binding G-protein-coupled receptors (GPCRs), considered more druggable …
elsevier.com
sci-hub.se 参考文章(76)
Peter J. Sinclair, Emerging Topics in Atherosclerosis: HDL Raising Therapies Annual Reports in Medicinal Chemistry Volume 40. ,vol. 40, pp. 71- 83 ,(2005) , 10.1016/S0065-7743(05)40005-6
Paul L McCormack, Gillian M Keating, Prolonged-release nicotinic acid: a review of its use in the treatment of dyslipidaemia Drugs. ,vol. 65, pp. 2719- 2740 ,(2005) , 10.2165/00003495-200565180-00014
Victoria L. Bautch, Enrico Solcia, Stephen R. Bloom, Seth G N Grant, Guido Rindi, Mohammed A. Ghatei, Yiangos Yiangou, Yiangos Yiangou, Julia M. Polak, Development of neuroendocrine tumors in the gastrointestinal tract of transgenic mice. Heterogeneity of hormone expression. American Journal of Pathology. ,vol. 136, pp. 1349- 1363 ,(1990)
Andrew J Krentz, Clifford J Bailey, Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs. ,vol. 65, pp. 385- 411 ,(2005) , 10.2165/00003495-200565030-00005
Charles D Wroe, 41st Annual Meeting of the European Association for the study of Diabetes Practical Diabetes International. ,vol. 23, pp. 86- 89 ,(2006) , 10.1002/PDI.905
D. A. H. Farningham, C. C. Whyte, The role of propionate and acetate in the control of food intake in sheep British Journal of Nutrition. ,vol. 70, pp. 37- 46 ,(1993) , 10.1079/BJN19930103
David Baker, Gareth Pryce, Wayne L. Davies, C. Robin Hiley, In silico patent searching reveals a new cannabinoid receptor. Trends in Pharmacological Sciences. ,vol. 27, pp. 1- 4 ,(2006) , 10.1016/J.TIPS.2005.11.003
Vincent Poitout, The ins and outs of fatty acids on the pancreatic β cell Trends in Endocrinology & Metabolism. ,vol. 14, pp. 201- 203 ,(2003) , 10.1016/S1043-2760(03)00086-9
Scott M. Grundy, Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy Nature Reviews Drug Discovery. ,vol. 5, pp. 295- 309 ,(2006) , 10.1038/NRD2005
John P. Overington, Bissan Al-Lazikani, Andrew L. Hopkins, How many drug targets are there Nature Reviews Drug Discovery. ,vol. 5, pp. 993- 996 ,(2006) , 10.1038/NRD2199